A simple portfolio of a few low-cost index funds is likely to outperform the most complicated, expensive investment products on Wall Street. Called Lazy Portfolios, these investment strategies work if you have $100 or $100 million to invest.
During the last session, Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $2.49, reflecting an intraday gain of 1.63% or $0.04. The 52-week high for the SIOX share is $5.74, that puts it down -130.52 from that peak though still a striking 25.3% gain since the share price plummeted to a 52-week low of $1.86. The company’s market capitalization is $144.27M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 625.18K shares over the past three months.
Author Bio
After producing excellent results in Marketing Operations for over 16 years, and being a business owner prior to that, Jeff has developed a strong understanding of business success and a keen eye for data and detail. Combined with investing experience going back 30 years to his first investment in mutual funds, his knowledge and interests have led him to the role of a contract writer for The Motley Fool.
In May 2021, Fidelity Investments announced a new Fidelity Youth Account aimed at making it easier for teens ages 13 to 17 to save money and become individual investors. In a few years from now, we may look back on this event and realize that it was just the beginning for a new line of young investors looking to become the next Warren Buffett, owner of
In last trading session, Sio Gene Therapies Inc. (NASDAQ:SIOX) saw 563,596 shares changing hands with its beta currently measuring 1.72. Company’s recent per share price level of $2.67 trading at $0.19 or 7.66% at ring of the bell on the day assigns it a market valuation of $156.86 Million. That closing price of SIOX’s stock is at a discount of -114.98% from its 52-week high price of $5.74 and is indicating a premium of 30.34% from its 52-week low price of $1.86. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 834.2 Million shares which gives us an average trading volume of 1.58 Million if we extend that period to 3-months.
Will Warren Buffettâs Successor Remain An Apple Stock Bull?
Warren Buffett, a celebrity Apple fan, has announced his successor as Berkshire Hathawayâs CEO. Could the transition of power lead to the conglomerate selling its Apple stock position?
Author:
May 4, 2021
Berkshire Hathaway’s Warren Buffett has recently made an important announcement. The first in line to take over control of the company will be the CEO of its energy division, Greg Abel.
As Apple stock’s portfolio represents about 45% of Berkshire’s portfolio, and because Berkshire is a top 3 investor in the Cupertino company’s equity, an obvious question has come up: under the new chief executive, would Berkshire be as bullish on Apple stock as it currently is?